Genesis Healthcare Reports Second Quarter 2016 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- S&P on track for muted open as Middle East tensions weigh; AI stocks boost Nasdaq
- Trump threatens to bomb Oman over Iran stance
- Why this Wall Street strategist says the "trade is long gold"
- U.S. EV market shows signs of bottoming out: Bernstein
- Micron rises as White House presses Apple to avoid Chinese memory chips
- L3Harris CEO steps down amid conduct review, shares drop
- Reddit leads social media platforms in revenue growth per user
- Northland Upgrades Astera Labs (ALAB) to Outperform, 'Right Time, Customers, and Products'
- Fulcrum Therapeutics to merge with Slate Medicines in all-stock deal
- S&P on track for muted open as Middle East tensions weigh; AI stocks boost Nasdaq
Genesis HealthCare (GEN) Misses Q2 EPS by 27c
August 4, 2016 4:52 PM EDTGenesis HealthCare (NYSE: GEN) reported Q2 EPS of ($0.26), $0.27 worse than the analyst estimate of $0.01. Revenue for the quarter came in at $1.44 billion versus the consensus estimate of $1.4 billion.
For earnings history and earnings-related data on Genesis HealthCare (GEN) click here.
... More